Uterocervical Angle: a Screening Tool That Estimates the Latent Phase Duration in Post Term Pregnancies
Anterior Uterocervical Angle for Latent Phase Duration in Post Term Pregnancies
1 other identifier
interventional
90
1 country
1
Brief Summary
To evaluate the performance of uterocervical angle (UCA) in the prediction of latent phase duration in post term pregnancies
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2020
CompletedFirst Submitted
Initial submission to the registry
April 9, 2021
CompletedFirst Posted
Study publicly available on registry
April 19, 2021
CompletedApril 19, 2021
April 1, 2021
5 months
April 9, 2021
April 13, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
prediction of latent phase duration by uterocervical angle in post term pregnancies
In patients diagnosed with late term pregnancy, the uterocervical angle and cervical length were measured by transvaginal ultrasound (TVUS) at the time of admission to the delivery room before labor induction.
5 months
Secondary Outcomes (1)
the relative success of UCA in active phase and duration of labor prediction in post term pregnancies
5 months
Study Arms (1)
uterocervical angle
OTHERuterocervical angle is the angle between lower segment of uterus and cervix
Interventions
uterocervical angle is the angle between lower segment of uterus and cervix
Eligibility Criteria
You may qualify if:
- Patients with singleton pregnancies
- Post term pregnancies
- Patients with vertex presentation,
- Patients with intact membranes
- Patients with no uterine contractions
You may not qualify if:
- women with BMI \>30,
- multiparity and multiple pregnancies,
- patients with macrosomia (\>4500 gr),
- patients with major fetal congenital abnormality or fetal death and any contraindications to vaginal birth (e.g. active genital herpes),
- patients with abnormal Pap smears,
- patients with a history of previous cesarean section, myomectomy, hysteroscopic surgeries, dilatation and curettages, loop electrosurgical excision procedures, and cervical conization.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nefise Nazlı Yenigül
Bursa, 16110, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph.D. Assistant Professor Department of Obstetrics and Gynecolog
Study Record Dates
First Submitted
April 9, 2021
First Posted
April 19, 2021
Study Start
June 1, 2020
Primary Completion
October 30, 2020
Study Completion
October 30, 2020
Last Updated
April 19, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share